Sumitomo Mitsui Trust Holdings, Inc. Ionis Pharmaceuticals Inc Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

$156 Billion
Q2 2025

A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 139,739 shares of IONS stock, worth $10.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

139,739

Previous 142,433 1.89%

Holding current value

$10.2 Million

Previous $4.3 Million 28.48%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 31, 2025	SELL	$25.51 - $40.0 $68,723 - $107,760	-2,694 Reduced 1.89%	139,739 $5.52 Million
Q1 2025 Apr 25, 2025	SELL	$30.17 - $34.97 $429,138 - $497,413	-14,224 Reduced 9.08%	142,433 $4.3 Million
Q4 2024 Jan 28, 2025	SELL	$33.73 - $40.36 $1.33 Million - $1.59 Million	-39,457 Reduced 20.12%	156,657 $5.48 Million
Q3 2024 Nov 05, 2024	SELL	$40.06 - $51.86 $124,867 - $161,647	-3,117 Reduced 1.56%	196,114 $7.86 Million
Q2 2024 Jul 19, 2024	SELL	$36.45 - $47.7 $766,543 - $1 Million	-21,030 Reduced 9.55%	199,231 $9.5 Million
Q1 2024 Apr 19, 2024	SELL	$42.03 - $53.55 $1.35 Million - $1.72 Million	-32,198 Reduced 12.75%	220,261 $9.55 Million
Q4 2023 Jan 30, 2024	SELL	$43.39 - $51.63 $1.74 Million - $2.07 Million	-40,014 Reduced 13.68%	252,459 $12.8 Million
Q3 2023 Oct 30, 2023	SELL	$38.5 - $47.13 $140,871 - $172,448	-3,659 Reduced 1.24%	292,473 $13.3 Million
Q2 2023 Jul 31, 2023	SELL	$34.73 - $43.33 $46,434 - $57,932	-1,337 Reduced 0.45%	296,132 $12.2 Million
Q1 2023 Apr 27, 2023	SELL	$33.58 - $41.2 $1.32 Million - $1.62 Million	-39,263 Reduced 11.66%	297,469 $10.6 Million
Q4 2022 Jan 30, 2023	SELL	$37.12 - $46.52 $3.73 Million - $4.67 Million	-100,444 Reduced 22.98%	336,732 $12.7 Million
Q3 2022 Oct 21, 2022	SELL	$36.54 - $48.66 $1.13 Million - $1.51 Million	-30,940 Reduced 6.61%	437,176 $19.3 Million
Q2 2022 Jul 26, 2022	SELL	$31.71 - $43.0 $4.17 Million - $5.65 Million	-131,500 Reduced 21.93%	468,116 $17.3 Million
Q1 2022 Apr 27, 2022	SELL	$29.88 - $37.04 $187,825 - $232,833	-6,286 Reduced 1.04%	599,616 $22.2 Million
Q4 2021 Feb 02, 2022	SELL	$25.61 - $35.1 $2.04 Million - $2.8 Million	-79,758 Reduced 11.63%	605,902 $18.4 Million
Q3 2021 Oct 25, 2021	BUY	$33.54 - $40.55 $5.41 Million - $6.54 Million	161,334 Added 30.77%	685,660 $23 Million
Q2 2021 Aug 02, 2021	SELL	$34.54 - $47.25 $13 Million - $17.8 Million	-376,975 Reduced 41.83%	524,326 $20.9 Million
Q1 2021 Apr 30, 2021	BUY	$42.51 - $63.78 $5.81 Million - $8.71 Million	136,617 Added 17.87%	901,301 $40.5 Million
Q4 2020 Feb 05, 2021	BUY	$45.3 - $60.27 $1.17 Million - $1.56 Million	25,867 Added 3.5%	764,684 $43.2 Million
Q3 2020 Oct 30, 2020	SELL	$47.45 - $62.95 $2.21 Million - $2.93 Million	-46,612 Reduced 5.93%	738,817 $35.1 Million
Q2 2020 Jul 27, 2020	SELL	$46.85 - $61.05 $6.36 Million - $8.29 Million	-135,758 Reduced 14.74%	785,429 $46.3 Million
Q1 2020 Apr 27, 2020	SELL	$41.6 - $63.4 $2.04 Million - $3.11 Million	-48,996 Reduced 5.05%	921,187 $43.6 Million
Q4 2019 Jan 31, 2020	BUY	$53.85 - $65.27 $5.64 Million - $6.84 Million	104,720 Added 12.1%	970,183 $58.6 Million
Q3 2019 Oct 31, 2019	BUY	$59.06 - $72.15 $3.57 Million - $4.36 Million	60,363 Added 7.5%	865,463 $51.9 Million
Q2 2019 Jul 29, 2019	BUY	$62.09 - $86.14 $39.1 Million - $54.2 Million	629,275 Added 357.9%	805,100 $51.7 Million
Q1 2019 May 08, 2019	BUY	$52.92 - $81.17 $9.3 Million - $14.3 Million	175,825 New	175,825 $14.3 Million

Others Institutions Holding IONS

# of Institutions

416

Shares Held

149M

Call Options Held

1.72M

Put Options Held

722K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $10.4B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.

Account

Sumitomo Mitsui Trust Holdings, Inc. Ionis Pharmaceuticals Inc Transaction History